Workflow
Trinity Capital (TRIN)
icon
Search documents
Capital Southwest and Trinity Capital Announce Formation of New Joint Venture
Prnewswire· 2026-03-16 12:00
Core Viewpoint - Capital Southwest Corporation and Trinity Capital Inc. have formed a joint venture to invest primarily in first-out senior secured debt opportunities in the lower middle market [1][2]. Group 1: Joint Venture Structure - The joint venture will be equally owned by both companies, with each committing $50 million and holding a 50% equity interest [2]. - Investment and operational decisions will be managed by a board of managers with equal representation from both partners [2]. Group 2: Strategic Benefits - The joint venture is expected to enhance Capital Southwest's ability to compete for high-quality lower middle market opportunities by providing more flexible capital solutions [3]. - Trinity Capital aims to diversify its portfolio into the lower middle market and expand its managed funds business through this partnership [3]. Group 3: Company Profiles - Capital Southwest Corporation, based in Dallas, Texas, has approximately $2.0 billion in investments at fair value as of December 31, 2025, focusing on middle market businesses with investments ranging from $5 million to $50 million [4]. - Trinity Capital Inc., headquartered in Phoenix, Arizona, is an international alternative asset manager that focuses on private credit markets across five distinct lending verticals [5].
The S&P 500 Dropped 2.5% and These 2 Closed-End Funds Held Their Ground
Yahoo Finance· 2026-03-16 09:29
Company Overview - Trinity Capital operates as a Business Development Company (BDC), focusing on lending to growth-stage companies rather than investing in public equities [1] - GGT is a closed-end fund managed by Gabelli Funds, investing in media and telecommunications companies, with a fixed share count that can trade at a discount or premium [2] Financial Performance - Trinity's revenue for 2025 grew 24% year-over-year to $293.7 million, with a dividend coverage ratio of 102% [5][8] - GGT has maintained uninterrupted distributions for over 26 years, recently increasing monthly payments to $0.07 to $0.08 per share [5][2] Market Position and Stability - Both Trinity Capital and Gabelli Multimedia Trust outperformed the S&P 500 over the past month, with GGT up 0.48% and TRIN up 0.10%, while the S&P 500 fell approximately 4.3% [5][7] - The elevated VIX at 27.29 indicates increased market uncertainty, driving income-focused investors towards BDCs and closed-end funds like Trinity and GGT [4][3] Dividend and Yield - Trinity's effective yield on its debt portfolio was 15.2% in Q4 2025, with a shift to monthly dividend payments of $0.17 per share starting January 2026 [1] - GGT's return engine relies on the appreciation of its media-sector holdings and steady distributions, transitioning to monthly payments [2] Investment Considerations - Trinity's share count increased from 59.4 million to 77 million year-over-year, which diluted existing shareholders despite total earnings growth [11] - GGT's concentration in the media sector exposes it to structural headwinds, reflected in its five-year total return of -12% [12]
Deploy Cash Now Into Double-Digit Yielding Passive Income
Seeking Alpha· 2026-03-14 12:15
Group 1 - The article suggests that now is an opportune time for investors to start deploying cash positions that have been accumulated recently [1] - Austin Rogers is identified as a REIT specialist focused on high-quality dividend growth stocks, aiming to generate a safe and growing passive income stream [2] - The investing group High Yield Landlord is highlighted as one of the largest real estate investment communities on Seeking Alpha, providing exclusive research and multiple real money portfolios [2] Group 2 - The analyst has disclosed a beneficial long position in several stocks, indicating a personal investment interest in ARES, BX, BAM, CGDG, TDIV, HTGC, TRIN, and IIPR.PR.A [3] - Seeking Alpha emphasizes that past performance does not guarantee future results and that no specific investment recommendations are being made [4]
Trinity Capital Inc. Provides $35 Million in Growth Capital to Monteris Medical to Support Neurosurgical Technology Advancements
Prnewswire· 2026-03-12 13:25
Core Insights - Trinity Capital Inc. has committed $35 million in growth capital to Monteris Medical, a MedTech company focused on minimally invasive neurosurgical technology [1] - Monteris Medical's NeuroBlate System utilizes MRI-guided laser technology for the treatment of brain tumors, radiation necrosis, and drug-resistant epilepsy, offering a less invasive alternative to traditional neurosurgery [1] - The funding will support the commercialization of the NeuroBlate System and the expansion of clinical research programs [1] Company Overview - Trinity Capital Inc. is an international alternative asset manager that aims to provide consistent returns through private credit markets, having deployed over $5.5 billion across more than 463 investments since its inception in 2008 [1] - Monteris Medical specializes in MR-guided laser ablation systems for minimally invasive brain surgery, with the NeuroBlate System being the only LITT platform featuring a robotic interface [1] - The NeuroBlate System is designed for patients aged two and older, demonstrating benefits such as shorter hospital stays and lower complication rates compared to traditional surgical methods [1]
3 Analyst-Approved Stocks With Fat Yields That Could Rally 27% or More
Yahoo Finance· 2026-03-11 19:26
Core Viewpoint - The article discusses the appeal of business development companies (BDCs) as high-yield investment options compared to traditional dividend stocks, highlighting their requirement to distribute at least 90% of taxable income as dividends [2]. Group 1: Investment Opportunities - BDCs are noted for offering double-digit yields, making them attractive for investors seeking higher returns [2]. - Trinity Capital Inc is identified as a leading BDC, providing funding primarily to technology and life sciences sectors through venture debt and equipment financing [7]. - A recent loan of $35 million to Neuros Medical by Trinity Capital exemplifies its role in supporting growth for private biotech companies [8]. Group 2: Stock Selection Criteria - The selection of stocks was based on a screening process using Barchart's Stock Screener, focusing on high-yielding companies [3][4]. - The analysis included only companies rated "Moderate Buy" to "Strong Buy" by at least 12 analysts, ensuring a broad consensus on the stock ratings [6].
TRINZ: To Refi Or Not To Refi (Rating Downgrade)
Seeking Alpha· 2026-03-11 18:04
Group 1 - The company started covering the 7.875% Notes Due 2029 (TRINZ) from Trinity Capital (TRIN) last year, assigning a 'Buy' rating to the debentures [1] - The investment banking firm Binary Tree Analytics (BTA) aims to provide transparency and analytics in capital markets instruments and trades, focusing on CEFs, ETFs, and Special Situations [1] - BTA has over 20 years of investment experience, having obtained a Finance major from a top university [1]
Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR
Prnewswire· 2026-03-11 12:00
Core Insights - Emboline, Inc. has secured $20 million in growth capital from Trinity Capital to support the commercialization of its Emboliner® Embolic Protection System, aimed at minimizing stroke risk during transcatheter aortic valve replacement (TAVR) procedures [1][1][1] Company Overview - Emboline, Inc. is a privately held medical technology company based in Santa Cruz, California, focused on developing technologies to reduce embolic complications during transcatheter cardiovascular procedures [1][1] - The company's lead product, the Emboliner® Embolic Protection System, is designed to provide full cerebral and systemic embolic protection by capturing and removing debris released during structural heart interventions [1][1] Funding and Development - The funding from Trinity Capital will support Emboline's upcoming commercial launch activities and the continued development of its embolic protection technology platform [1][1] - Emboline has completed enrollment in the PROTECT H2H investigational device exemption (IDE) clinical trial, which evaluates the Emboliner® system [1][1] Clinical and Regulatory Milestones - Results from the completed IDE clinical study will be presented at the American College of Cardiology Annual Scientific Session on March 29, 2026 [1][1] - The financing positions Emboline to prepare for a commercial launch in the United States and Europe later this year [1][1] Strategic Partnerships - Trinity Capital, an international alternative asset manager, has a history of deploying over $5.5 billion across more than 463 investments since its inception in 2008, indicating a strong partnership for Emboline [1][1]
Trinity Capital Inc. Provides $20 Million in Growth Capital to Emboline, Inc. to Advance Interventional Heart Procedure Technology
Prnewswire· 2026-03-11 12:00
Core Insights - Trinity Capital Inc. has committed $20 million in growth capital to Emboline, Inc., a MedTech company focused on improving safety during interventional heart procedures [1] - Emboline's lead product, the Emboliner® Embolic Protection Catheter, aims to reduce the risk of strokes and other complications by capturing debris during minimally invasive heart procedures [1] - The financing will support Emboline in scaling manufacturing, expanding its team, and achieving clinical and regulatory milestones for the commercial launch of the Emboliner system [1] Company Overview - Trinity Capital Inc. is an international alternative asset manager that has deployed over $5.5 billion across more than 463 investments since its inception in 2008 [1] - The company focuses on providing tailored debt solutions across five lending verticals: Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences [1] - Emboline, Inc. is a privately held medical technology company based in Santa Cruz, California, dedicated to developing technologies that minimize embolic complications during cardiovascular procedures [1]
Trinity Capital: Strong Investment Setup (Rating Upgrade)
Seeking Alpha· 2026-03-03 17:07
Core Viewpoint - Trinity Capital (TRIN) is experiencing selling pressure due to concerns regarding the performance of Software as a Service (SaaS) loans within the Business Development Company (BDC) sector [1] Group 1: Company Performance - Trinity Capital, like other private credit companies, has faced challenges related to the performance of its loan portfolio, particularly in the SaaS segment [1] Group 2: Industry Context - The BDC sector is currently under scrutiny, with investors worried about the overall performance of loans, especially those tied to SaaS companies [1]
Trinity Capital: Not Your Typical 13%+ Yielding BDC
Seeking Alpha· 2026-02-27 14:15
Group 1 - Trinity Capital Inc. (TRIN) is highlighted as one of the top three Business Development Companies (BDCs) alongside Kayne Anderson BDC, Inc. (KBDC) and Fidus Investment (FDUS) [1] Group 2 - Roberts Berzins has over a decade of experience in financial management, focusing on helping top-tier corporates with financial strategies and large-scale financings [2] - He has contributed to institutionalizing the REIT framework in Latvia to enhance the liquidity of pan-Baltic capital markets [2] - His policy-level work includes developing national SOE financing guidelines and frameworks for channeling private capital into affordable housing [2]